DK1023265T3 - Azetidinonderivater til behandlingen af HCMV infektioner - Google Patents

Azetidinonderivater til behandlingen af HCMV infektioner

Info

Publication number
DK1023265T3
DK1023265T3 DK98947257T DK98947257T DK1023265T3 DK 1023265 T3 DK1023265 T3 DK 1023265T3 DK 98947257 T DK98947257 T DK 98947257T DK 98947257 T DK98947257 T DK 98947257T DK 1023265 T3 DK1023265 T3 DK 1023265T3
Authority
DK
Denmark
Prior art keywords
lower alkyl
phenyl
het
optionally substituted
alkyl
Prior art date
Application number
DK98947257T
Other languages
Danish (da)
English (en)
Inventor
Christiane Yoakim
Catherine Chabot
Robert Deziel
Stephen Kawai
Willian W Ogilvie
Jeffrey O'meara
Original Assignee
Boehringer Ingelheim Ca Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Ca Ltd filed Critical Boehringer Ingelheim Ca Ltd
Application granted granted Critical
Publication of DK1023265T3 publication Critical patent/DK1023265T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D205/00Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/20Antivirals for DNA viruses
    • A61P31/22Antivirals for DNA viruses for herpes viruses
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biotechnology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
DK98947257T 1997-10-07 1998-10-06 Azetidinonderivater til behandlingen af HCMV infektioner DK1023265T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US6154897P 1997-10-07 1997-10-07
PCT/CA1998/000954 WO1999018073A1 (en) 1997-10-07 1998-10-06 Azetidinone derivatives for the treatment of hcmv infections

Publications (1)

Publication Number Publication Date
DK1023265T3 true DK1023265T3 (da) 2003-02-24

Family

ID=22036473

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98947257T DK1023265T3 (da) 1997-10-07 1998-10-06 Azetidinonderivater til behandlingen af HCMV infektioner

Country Status (10)

Country Link
US (1) US6211170B1 (https=)
EP (1) EP1023265B1 (https=)
JP (1) JP2001519330A (https=)
AT (1) ATE231124T1 (https=)
AU (1) AU9426198A (https=)
CA (1) CA2301967C (https=)
DE (1) DE69810800T2 (https=)
DK (1) DK1023265T3 (https=)
ES (1) ES2187064T3 (https=)
WO (1) WO1999018073A1 (https=)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA91341C2 (ru) 2004-07-15 2010-07-26 Амр Текнолоджи, Інк. Арил- и гетероарилзамещенные тетрагидроизохинолины и их применение для блокирования обратного захвата норэпинефрина, допамина и серотонина
GB0608899D0 (en) * 2006-05-05 2006-06-14 Leuven K U Res & Dev Novel viral replication inhibitors
ES2428326T3 (es) * 2007-10-04 2013-11-07 Merck Sharp & Dohme Corp. Derivados de aril sulfona sustituida como bloqueadores de canales de calcio
US9156812B2 (en) 2008-06-04 2015-10-13 Bristol-Myers Squibb Company Crystalline form of 6-[(4S)-2-methyl-4-(2-naphthyl)-1,2,3,4-tetrahydroisoquinolin-7-yl]pyridazin-3-amine
US8815894B2 (en) * 2009-05-12 2014-08-26 Bristol-Myers Squibb Company Crystalline forms of (S)-7-([1,2,4]triazolo[1,5-a]pyridin-6-yl)-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydroisoquinoline and use thereof
EP2429295B1 (en) * 2009-05-12 2013-12-25 Albany Molecular Research, Inc. Aryl, heteroaryl, and heterocycle substituted tetrahydroisoquinolines and use thereof
AU2010247763B2 (en) * 2009-05-12 2015-12-24 Albany Molecular Research, Inc. 7-([1,2,4,]triazolo[1,5,-a]pyridin-6-yl)-4-(3,4-dichlorophenyl)-1,2,3,4- tetrahydroisoquinoline and use thereof
US9216180B2 (en) 2012-10-02 2015-12-22 New York University Pharmaceutical compositions and treatment of genetic diseases associated with nonsense mediated RNA decay
AU2019339777B2 (en) 2018-09-12 2022-09-01 Novartis Ag Antiviral pyridopyrazinedione compounds
AU2020353055B2 (en) 2019-09-26 2024-03-07 Gilead Sciences, Inc. Antiviral pyrazolopyridinone compounds

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5229381A (en) 1983-12-01 1993-07-20 Merck & Co., Inc. Substituted azetidinones as anti-inflammatory and antidegenerative agents
US4680391A (en) 1983-12-01 1987-07-14 Merck & Co., Inc. Substituted azetidinones as anti-inflammatory and antidegenerative agents
IL89835A0 (en) * 1988-04-11 1989-12-15 Merck & Co Inc Substituted azetidinones,their preparation and pharmaceutical compositions containing them
EP0377549B1 (en) 1989-01-03 1998-12-09 Marcos Y. Kleinerman Remote measurement of physical variables with fiber optic systems
US5100880A (en) * 1991-03-20 1992-03-31 Merck & Co., Inc. Novel betalactam elastase inhibitors containing phosphorous acid derivatives at the 4-position of the 2-azetidinone
US5104862A (en) * 1991-03-20 1992-04-14 Merck & Co., Inc. Bethalactam elastase inhibitors containing phosphorous acid derivatives at the 4-position of the 2-azetidinone
GB2266527A (en) * 1992-03-17 1993-11-03 Merck & Co Inc Substituted azetidinones useful in the treatment of leukemia
GB9314350D0 (en) 1993-07-12 1993-08-25 Zeneca Ltd Armide derivatives
US5900401A (en) * 1994-03-23 1999-05-04 Tokyo Tanabe Company Limited Remedy for respiratory-tract viral disease

Also Published As

Publication number Publication date
JP2001519330A (ja) 2001-10-23
DE69810800D1 (de) 2003-02-20
WO1999018073A1 (en) 1999-04-15
ATE231124T1 (de) 2003-02-15
US6211170B1 (en) 2001-04-03
EP1023265A1 (en) 2000-08-02
ES2187064T3 (es) 2003-05-16
AU9426198A (en) 1999-04-27
EP1023265B1 (en) 2003-01-15
DE69810800T2 (de) 2003-09-18
CA2301967A1 (en) 1999-04-15
CA2301967C (en) 2005-05-17

Similar Documents

Publication Publication Date Title
ATE222894T1 (de) Substituierte aminophenylisoxazolinderivate verwendbar als antimikrobielle agenzien
BG102792A (bg) Производни на заместени 4-хидроксифенилалканоилови киселини с агонистична активност към рраr-гама
ATE186909T1 (de) Cyclische fungizide amide
DK1021405T3 (da) Azetidinonderivater til behandling af HCMV-infektioner
AU2910600A (en) Phenyl urea and phenyl thiourea derivatives
DE60005504D1 (de) Chinolinderivate als mek enzym-inhibitoren
NO975901D0 (no) Vinyl-pyrrolidinon cefalosporiner med basiske substituenter
DK1023265T3 (da) Azetidinonderivater til behandlingen af HCMV infektioner
SE0201937D0 (sv) Therapeutic agents
FI925871A0 (fi) Menetelmä terapeuttisesti aktiivisten fenyyliguanidiinijohdannaisten valmistamiseksi
ATE497948T1 (de) Bicyclische verbindungen
DE69434720D1 (de) Verwendung von 2,6-Dialkyl-4-Silyl-Phenol Derivaten zur Behandlung von Xanthom
DE69401136D1 (de) Modifizierte Oligodeoxyribonukleotide, ihre Herstellung und ihre therapeutische Verwendung
DK1021404T3 (da) Azetidinonderivater til behandling af HCMV-infektioner
NZ336368A (en) Substituted pyrazole-3-yl benzazoles and their use as herbicides
MX9606531A (es) Compuestos farmaceuticos.
ATE215075T1 (de) Hydroxylamin-derivate mit anti-ischämischer wirkung und pharmazeutische zusammensetzungen diese enthaltend
MX9708422A (es) Esteres de carbapenemas.
NZ336876A (en) Process for preparation of 4-H-4-oxo-quinolizine-3-carboxylic acid derivatives
CO5261568A1 (es) Oxazolidinonas derivadas de sultamas o sultonas